In Kenya, a retrospective analysis of HPV Dose 1 data from the national health information system (2019–2025) reveals a pronounced cyclical uptake pattern, with quarterly doses ranging from a low of 21,764 (Q1 2025) to a peak of 564,403 (Q4 2021), with surges consistently linked to intensified outreach campaigns and school calendar alignment and sharp […]
Topic: Health Information Systems
Using Geographic information System mapping for Evidence-Based Planning to Reach HPV vaccine Target Girls and Zero-Dose Children: Experience from Jigjiga Town, Ethiopia.
In Ethiopia, a 20-day house-to-house GIS mapping exercise conducted in Jigjiga town (Somali region) between August and September 2024 revealed major discrepancies between projected and actual target populations: official estimates placed the HPV-eligible girl population at 6,770, while the headcount identified 11,300 — a 67% undercount — and 14,935 girls were ultimately vaccinated, representing 132% […]
Health Information Systems and Data for Action: Q&A Session
In this Q&A following country presentations on health information systems, participants raised questions around four cross-cutting themes: reaching out-of-school girls, tracking HIV-positive adolescents requiring three HPV doses, managing data collection in low-connectivity rural areas, and the timeline and resources involved in transitioning from paper-based to digital systems. Cameroon’s representative described how opposition from Catholic churches […]
Health Information Systems and Data for Action: Tanzania
In Tanzania, health information systems underpin the planning and monitoring of HPV vaccination across a country of over 67 million people and more than 12,000 health facilities. At the facility level, paper-based tools remain in use, while from the district upward, the Vaccine Information Management System (VIMS) consolidates routine immunization reporting, vaccine stock data, and […]
Health Information Systems and Data for Action: Rwanda
In Rwanda, HPV vaccination data management has undergone a comprehensive transition from paper-based registers to integrated digital systems. Prior to 2022, health workers manually aggregated vaccination counts at month-end and reported them to HMIS, a process prone to human error, delays, and data fragmentation. Since 2020, the e-Tracker/DHIS2 system records individual client immunization data, enabling […]
Health Information Systems and Data for Action: Cameroon
In Cameroon, DHIS2 centralizes health data from approximately 6,000 health facilities, with monthly reporting cascading from facility to district, regional, and national levels. The presentation identifies five key gaps in the HPV health information system: limited integration of school registers into microplanning, absence of age-cohort disaggregation for catch-up targets, delayed and incomplete facility reporting, lack […]
Challenges and good practices for sustaining delivery after a MAC introduction: Nigeria’s experience towards cervical cancer elimination
In Nigeria, HPV vaccination was introduced in two phases — Phase 1 targeting 16 states (2023) and Phase 2 covering 21 additional states (October 2024) — with immediate routinization following each mass multi-age cohort (MAC) campaign. Combined MAC and routine delivery reached approximately 15.3 million girls aged 9–14 since introduction, with over 12.3 million vaccinated […]
Suivi et évaluation au niveau national, y compris les outils de compte-rendu, la supervision et l’évaluation de l’impact: Séance questions-réponses
La session a souligné que l’efficacité des programmes repose sur la qualité des données, la Côte d’Ivoire utilisant des registres dédiés et un suivi intégré pour la vaccination HPV. Les principaux défis concernent les pénuries de vaccins limitant le rattrapage des filles plus âgées et la collecte de données pour les populations immunodéprimées, au-delà du […]
Suivi et évaluation au niveau national, y compris les outils de compte-rendu, la supervision et l’évaluation de l’impact : expérience de la Cote d’Ivoire
La Côte d’Ivoire a intégré la vaccination contre le HPV dans son programme de vaccination de routine en novembre 2019, en renforçant les systèmes de données pour garantir son efficacité. Le suivi s’appuie sur des registres spécifiques, des rapports mensuels via le DHIS2 et une supervision intégrée à tous les niveaux du système de santé. […]
Suivi et évaluation au niveau national, y compris les outils de compte-rendu, la supervision et l’évaluation de l’impact : expérience du Mauritanie
Le programme de vaccination contre le HPV en Mauritanie a été introduit dans un contexte difficile, marqué par des pénuries de vaccins et la pandémie de COVID-19. Malgré ces contraintes, le pays a atteint près de 70 % de couverture pour la première dose lors des campagnes initiales et a mis en place des systèmes […]